Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group-Reference-Cited by-同舟云学术

Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group

Published:2010-01 Issue:1 Volume:21 Page:61-66
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Lorusso D.,Ferrandina G.,Pignata S.,Ludovisi M.,Viganò R.,Scalone S.,Scollo P.,Breda E.,Pietragalla A.,Scambia G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/1/61/337705/mdp266.pdf

Reference51 articles.

1. Globocan 2000. Cancer Incidence, Mortality and Prevalence Worldwide;Ferlay,2001

2. Optimizing treatment for cervical cancer: the value of chemoradiation;Green;Am J Cancer,2004

3. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials;Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration;Eur J Cancer,2003

4. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group;Thigpen;Cancer,1981

5. Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study;Sutton;Invest New Drugs,1989

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Oral Metronomic Chemotherapy in Recurrent Refractory Advanced Gynaecological Cancer: An Experience From the Regional Cancer Centre of Eastern India;Cureus;2024-01-30

2. Radiotherapy outcomes in patients with locally advanced cervical carcinoma and previous hysterectomy: a retrospective analysis;REV COLOMB CANCEROL;2023

3. Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022–2023 : Prise en charge du cancer du col de l'utérus avancé;Bulletin du Cancer;2023-06

4. The evolving landscape of antibody-drug conjugates in gynecologic cancers;Cancer Treatment Reviews;2023-05

5. Tratamiento del cáncer de cuello uterino en estadio III y IV;EMC - Ginecología-Obstetricia;2023-02